CN113577189B - Traditional Chinese medicine composition for poultry and preparation method and application thereof - Google Patents
Traditional Chinese medicine composition for poultry and preparation method and application thereof Download PDFInfo
- Publication number
- CN113577189B CN113577189B CN202110890039.5A CN202110890039A CN113577189B CN 113577189 B CN113577189 B CN 113577189B CN 202110890039 A CN202110890039 A CN 202110890039A CN 113577189 B CN113577189 B CN 113577189B
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- poultry
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 86
- 239000000203 mixture Substances 0.000 title claims abstract description 48
- 244000144977 poultry Species 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title abstract description 18
- 230000036039 immunity Effects 0.000 claims abstract description 18
- 240000006079 Schisandra chinensis Species 0.000 claims abstract description 17
- 235000008422 Schisandra chinensis Nutrition 0.000 claims abstract description 16
- 235000010726 Vigna sinensis Nutrition 0.000 claims abstract description 15
- 235000001405 Artemisia annua Nutrition 0.000 claims abstract description 14
- 240000000011 Artemisia annua Species 0.000 claims abstract description 14
- 229940079593 drug Drugs 0.000 claims description 26
- 238000002156 mixing Methods 0.000 claims description 26
- 239000000706 filtrate Substances 0.000 claims description 22
- 235000006533 astragalus Nutrition 0.000 claims description 21
- 229920001353 Dextrin Polymers 0.000 claims description 19
- 239000004375 Dextrin Substances 0.000 claims description 19
- 235000019425 dextrin Nutrition 0.000 claims description 19
- 229930006000 Sucrose Natural products 0.000 claims description 18
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 18
- 239000005720 sucrose Substances 0.000 claims description 18
- 241000007126 Codonopsis pilosula Species 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 15
- 241000219977 Vigna Species 0.000 claims description 14
- 239000002245 particle Substances 0.000 claims description 13
- 208000035240 Disease Resistance Diseases 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 11
- 230000002829 reductive effect Effects 0.000 claims description 11
- 230000002708 enhancing effect Effects 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 10
- 238000010298 pulverizing process Methods 0.000 claims description 9
- 241000045403 Astragalus propinquus Species 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000002994 raw material Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 16
- 201000010099 disease Diseases 0.000 abstract description 15
- 241001465754 Metazoa Species 0.000 abstract description 11
- 240000002948 Ophiopogon intermedius Species 0.000 abstract description 11
- 244000144972 livestock Species 0.000 abstract description 10
- 239000004480 active ingredient Substances 0.000 abstract description 7
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 235000013399 edible fruits Nutrition 0.000 abstract description 3
- 206010011224 Cough Diseases 0.000 abstract description 2
- 229940107666 astragalus root Drugs 0.000 abstract description 2
- 230000007812 deficiency Effects 0.000 abstract description 2
- 239000012530 fluid Substances 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 244000042314 Vigna unguiculata Species 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 30
- 235000013594 poultry meat Nutrition 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 17
- 241000287828 Gallus gallus Species 0.000 description 16
- 235000013330 chicken meat Nutrition 0.000 description 16
- 241001061264 Astragalus Species 0.000 description 15
- 210000004233 talus Anatomy 0.000 description 15
- 230000001717 pathogenic effect Effects 0.000 description 14
- 208000010359 Newcastle Disease Diseases 0.000 description 10
- 208000002979 Influenza in Birds Diseases 0.000 description 7
- 206010064097 avian influenza Diseases 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229960005486 vaccine Drugs 0.000 description 6
- 210000001835 viscera Anatomy 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000005714 functional activity Effects 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 241000271566 Aves Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 235000014134 echinacea Nutrition 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000000091 immunopotentiator Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 208000031295 Animal disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 244000133098 Echinacea angustifolia Species 0.000 description 1
- 240000004530 Echinacea purpurea Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 206010062016 Immunosuppression Diseases 0.000 description 1
- 235000000421 Lepidium meyenii Nutrition 0.000 description 1
- 240000000759 Lepidium meyenii Species 0.000 description 1
- 231100000678 Mycotoxin Toxicity 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 208000027954 Poultry disease Diseases 0.000 description 1
- 235000003713 Rhodiola rosea Nutrition 0.000 description 1
- 244000042430 Rhodiola rosea Species 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000006353 environmental stress Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000008642 heat stress Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000008076 immune mechanism Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 229960003971 influenza vaccine Drugs 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 235000012902 lepidium meyenii Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000002636 mycotoxin Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007084 physiological dysfunction Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/70—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for poultry, and relates to the field of traditional Chinese medicines for livestock. The traditional Chinese medicine composition contains active ingredients, wherein the active ingredients comprise: astragalus root, pilose asiabell root, dwarf lilyturf tuber, schisandra fruit, cowpea, chinese fevervine herb, sweet wormwood herb and manninoligosaccharide. The pharmaceutical composition has the effects of tonifying qi, securing essence, strengthening body resistance, consolidating primordial qi, promoting fluid production, tonifying deficiency, relieving cough and asthma, and is suitable for animals to strengthen immunity and prevent diseases. The pharmaceutical composition has the characteristics of precise and appropriate formula, definite curative effect, high safety, stable preparation, controllable quality, simple preparation process, suitability for industrial production and the like.
Description
Technical Field
The invention relates to the field of veterinary traditional Chinese medicines, in particular to a traditional Chinese medicine composition for poultry and a preparation method and application thereof.
Background
The intensive large-scale cultivation mode makes livestock and poultry in environments with high nutrition, high density, strong stress and overspeed growth become overwhelmed, so that the livestock and poultry have low immunity, weak disease resistance and greatly increased susceptibility to diseases, especially under the common existence of factors such as over immunity, mycotoxin, heavy metal pollution, immunosuppression diseases and the like, and large dosage of chemical medicines are used, the immune system of the animal organism is severely damaged, epidemic diseases are abused, the diseases are outbreak, a large number of livestock and poultry die, old diseases are continuously developed, new diseases are developed again, and huge harm is brought to the development of the cultivation industry. Even if the livestock and poultry are barely alive, most of the livestock and poultry are in a sub-health state for a long time, in order to enable the livestock and poultry to get rid of the sub-health state and maintain the high-speed growth and reproductive capacity of the livestock and poultry, the breeders have to use a large amount of medicines, vaccines and chemical additives, which greatly increases the risks of potential food safety hazards. Therefore, it is not easy to develop green, safe and efficient medicines for enhancing the immunity of organisms and improving the disease resistance.
The traditional Chinese medicine has unique advantages in the aspects of enhancing organism immunity and improving animal disease resistance, and becomes the most important field of current research. At present, most people in the field only consider the medicine with the immunity enhancing function when selecting the immunity enhancing medicine, but neglect the animal itself to be an organic whole, and the animal can not thoroughly eliminate the disease even if the animal body immunity is improved under the condition that the animal itself is ill, and the existing medicine only considers the immunity enhancing function of the animal body and neglects the disease resistance. The disease is developed and developed through the comparison of the forces between healthy qi and pathogenic factors and the changes of the excessive and weak growth, and the disease development and prognosis are directly affected.
Disclosure of Invention
In order to solve the technical problems, the invention aims to provide a safe and efficient traditional Chinese medicine composition for poultry.
The invention aims at realizing the following technical scheme:
the invention provides a traditional Chinese medicine composition for poultry, which contains active ingredients, wherein the active ingredients comprise: astragalus root, pilose asiabell root, dwarf lilyturf tuber, schisandra fruit, cowpea, chinese fevervine herb, sweet wormwood herb and manninoligosaccharide.
Further, the active ingredients are prepared from 20-70 parts by weight of astragalus mongholicus, 10-50 parts by weight of codonopsis pilosula, 10-40 parts by weight of radix ophiopogonis, 5-25 parts by weight of schisandra chinensis, 5-20 parts by weight of cowpea, 10-30 parts by weight of herba paederiae, 8-26 parts by weight of sweet wormwood and 70-100 parts by weight of mannooligosaccharide.
Further, the active ingredients are prepared from, by weight, 30-60 parts of astragalus mongholicus, 20-40 parts of codonopsis pilosula, 20-35 parts of radix ophiopogonis, 10-20 parts of schisandra chinensis, 8-16 parts of cowpea, 15-25 parts of Chinese fevervine, 12-22 parts of sweet wormwood herb and 80-90 parts of mannooligosaccharide.
Further, the active ingredients are prepared from 50 parts by weight of astragalus membranaceus, 30 parts by weight of codonopsis pilosula, 28 parts by weight of dwarf lilyturf tuber, 16 parts by weight of schisandra chinensis, 15 parts by weight of cowpea, 20 parts by weight of Chinese fevervine herb, 18 parts by weight of sweet wormwood herb and 85 parts by weight of mannooligosaccharide.
The invention also provides a preparation method of the traditional Chinese medicine composition for poultry, which comprises the following steps:
(1) The raw materials are respectively weighed according to the weight ratio.
(2) The preparation method comprises coarse pulverizing the above Chinese medicinal materials except for mannooligosaccharide, decocting with 10-12 times of water for 2-3 times each for 1-2 hr, filtering, mixing filtrates, and concentrating the filtrate under reduced pressure to obtain concentrated extract (1 g is equivalent to 3g of crude drug).
(3) Adding weighed mannooligosaccharide into the concentrated extract obtained in the step 2, uniformly mixing, adding sucrose and dextrin (the ratio of sucrose to dextrin is 1:1), uniformly mixing, and preparing into particles.
The traditional Chinese medicine composition for poultry can be used for enhancing the immunity of organisms and improving the disease resistance of poultry.
In particular to a medicine for enhancing the immunity of poultry and improving the disease resistance by preparing the traditional Chinese medicine composition for poultry. Preferably, the avian is an avian that has been vaccinated; preferably, the vaccinations are newcastle disease vaccines and avian influenza vaccines.
The invention also provides premix, concentrate and batch containing the traditional Chinese medicine composition for poultry.
Compared with the prior art, the traditional Chinese medicine composition has the following beneficial effects:
the traditional Chinese medicine composition is prepared by repeatedly verifying and practicing a large number of experiments according to the dialectical treatment theory of Chinese veterinary prescriptions, combines the immune mechanism of animal organisms and the reasons and clinical symptoms of partial diseases, and has obvious effects of improving the immunity and disease resistance of the organisms under the guidance of the dialectical treatment theory of traditional Chinese medicine through the precise prescription obtained by verifying a large number of clinical effects.
The occurrence of any disease is considered by the traditional Chinese medicine to be the result of struggle between the healthy qi and the pathogenic qi under certain conditions. The healthy qi is stored in the body, the pathogenic factors can not be dried, the pathogenic factors are accumulated, the qi is deficient, the disease is generated and developed, the strength contrast and the overgrowth and decline change between the healthy qi and the pathogenic factors exist all the time, and the disease development and the prognosis are directly affected. The defensive power of healthy qi is particularly characterized in the aspects of resisting invasion of exogenous evil, expelling evil, repairing and regulating ability, maintaining coordination of viscera and meridian functions and the like. The invasion of pathogenic qi mainly leads to physiological dysfunction, damage to the viscera and tissues, and changes in the body constitution. When healthy qi is greater than pathogenic qi, the body is in a healthy state, otherwise in a pathological state. So that the immunity and disease resistance of the organism are improved, and the healthy energy of the organism is improved. The therapeutic principle is to strengthen the body resistance and eliminate pathogenic factors, and the strengthening body resistance and eliminating pathogenic factors should be closely connected. Strengthening body resistance to enhance the body resistance of the livestock to defeat pathogenic factors; the pathogenic factors are eliminated to maintain healthy qi, that is, eliminate pathogenic factors, so that qi and blood of viscera of the livestock are recovered to be normal. The healthy qi of the middle-jiao veterinarian includes the functional activities of viscera, tissues and organs of the organism, the ability of the organism to resist environmental stress and the organism's resistance to pathogenic factors. To achieve what the veterinarian says "strengthening" one aspect, it is necessary to enhance "functional activities of the viscera, tissues and organs"; in order to enhance the functional activities of viscera, tissues and organs, the method of invigorating yang qi is needed. Such as spleen qi and kidney yang.
In the invention, astragalus and radix codonopsis can promote the production of body fluid and recover pulse, and greatly tonify primordial qi to be used as monarch drug; radix Ophiopogonis has effects of nourishing yin, promoting fluid production, and supplementing qi, and is used as ministerial drug; wu Wei Zi astringes yin to arrest sweating, engenders liquid to replenish qi, so it is good at astringing and gathering true qi for dissipation. The cowpea has the effects of dispelling wind and relieving cough, and resolving food stagnation, and is taken as an adjuvant drug; herba Paederiae has effects of dispelling pathogenic wind, promoting blood circulation, relieving pain, removing toxic substance, resolving food stagnation, eliminating dampness, relieving swelling, tonifying consumptive disease, regulating primordial qi of spleen and stomach, and reducing heat stress. Herba Artemisiae Annuae has effects of clearing deficiency heat, cooling blood, relieving summer heat, preventing malaria, increasing lymphocyte transformation rate, promoting organism cell immunity, and inhibiting bacteria and killing parasite. The medicines are combined together, and have the effects of nourishing yin, promoting the production of body fluid, tonifying qi, activating blood, promoting digestion, removing food stagnation and enhancing immunity.
According to the invention, the mannooligosaccharide is added on the basis of the traditional Chinese medicine composition, and experiments prove that the antibody level of the chick vaccinated with the newcastle disease vaccine can be further improved by combining the mannooligosaccharide and the traditional Chinese medicine composition. Meanwhile, compared with the existing products, the traditional Chinese medicine composition provided by the invention has excellent effects on improving the antibody level of poultry and preventing poultry diseases.
Detailed Description
The following examples are illustrative of the invention and are not intended to limit the scope of the invention.
Example 1
(1) Weighing the traditional Chinese medicinal materials with the following weight portions: 20 parts of astragalus, 10 parts of codonopsis pilosula, 10 parts of dwarf lilyturf tuber, 5 parts of schisandra chinensis, 5 parts of cowpea, 10 parts of Chinese fevervine herb, 8 parts of sweet wormwood herb and 70 parts of mannooligosaccharide.
(2) The preparation method comprises coarse pulverizing the above Chinese medicinal materials except for mannooligosaccharide, decocting with 10-12 times of water for 2-3 times each for 1-2 hr, filtering, mixing filtrates, and concentrating the filtrate under reduced pressure to obtain concentrated extract (1 g is equivalent to 3g of crude drug).
(3) Adding weighed mannooligosaccharide into the concentrated extract obtained in the step 2, uniformly mixing, adding sucrose and dextrin (the ratio of sucrose to dextrin is 1:1), uniformly mixing, and preparing into particles.
Example 2
(1) Weighing the traditional Chinese medicinal materials with the following weight portions: 70 parts of astragalus, 50 parts of codonopsis pilosula, 40 parts of dwarf lilyturf tuber, 25 parts of schisandra chinensis, 20 parts of cowpea, 30 parts of Chinese fevervine herb, 26 parts of sweet wormwood herb and 100 parts of mannooligosaccharide
(2) The preparation method comprises coarse pulverizing the above Chinese medicinal materials except for mannooligosaccharide, decocting with 10-12 times of water for 2-3 times each for 1-2 hr, filtering, mixing filtrates, and concentrating the filtrate under reduced pressure to obtain concentrated extract (1 g is equivalent to 3g of crude drug).
(3) Adding weighed mannooligosaccharide into the concentrated extract obtained in the step 2, uniformly mixing, adding sucrose and dextrin (the ratio of sucrose to dextrin is 1:1), uniformly mixing, and preparing into particles.
Example 3
(1) Weighing the traditional Chinese medicinal materials with the following weight portions: 30 parts of astragalus, 20 parts of codonopsis pilosula, 20 parts of dwarf lilyturf tuber, 10 parts of schisandra chinensis, 8 parts of cowpea, 15 parts of Chinese fevervine herb, 12 parts of sweet wormwood herb and 80 parts of mannooligosaccharide
(2) The preparation method comprises coarse pulverizing the above Chinese medicinal materials except for mannooligosaccharide, decocting with 10-12 times of water for 2-3 times each for 1-2 hr, filtering, mixing filtrates, and concentrating the filtrate under reduced pressure to obtain concentrated extract (1 g is equivalent to 3g of crude drug).
(3) Adding weighed mannooligosaccharide into the concentrated extract obtained in the step 2, uniformly mixing, adding sucrose and dextrin (the ratio of sucrose to dextrin is 1:1), uniformly mixing, and preparing into particles.
Example 4
(1) Weighing the traditional Chinese medicinal materials with the following weight portions: 60 parts of astragalus, 40 parts of codonopsis pilosula, 35 parts of dwarf lilyturf tuber, 20 parts of schisandra chinensis, 16 parts of cowpea, 25 parts of Chinese fevervine herb, 22 parts of sweet wormwood herb and 90 parts of mannooligosaccharide
(2) The preparation method comprises coarse pulverizing the above Chinese medicinal materials except for mannooligosaccharide, decocting with 10-12 times of water for 2-3 times each for 1-2 hr, filtering, mixing filtrates, and concentrating the filtrate under reduced pressure to obtain concentrated extract (1 g is equivalent to 3g of crude drug).
(3) Adding weighed mannooligosaccharide into the concentrated extract obtained in the step 2, uniformly mixing, adding sucrose and dextrin (the ratio of sucrose to dextrin is 1:1), uniformly mixing, and preparing into particles.
Example 5
(1) Weighing the traditional Chinese medicinal materials with the following weight portions: 50 parts of astragalus, 30 parts of codonopsis pilosula, 28 parts of dwarf lilyturf tuber, 16 parts of schisandra chinensis, 15 parts of cowpea, 20 parts of Chinese fevervine herb, 18 parts of sweet wormwood herb and 85 parts of mannooligosaccharide.
(2) The preparation method comprises coarse pulverizing the above Chinese medicinal materials except for mannooligosaccharide, decocting with 10-12 times of water for 2-3 times each for 1-2 hr, filtering, mixing filtrates, and concentrating the filtrate under reduced pressure to obtain concentrated extract (1 g is equivalent to 3g of crude drug).
(3) Adding weighed mannooligosaccharide into the concentrated extract obtained in the step 2, uniformly mixing, adding sucrose and dextrin (the ratio of sucrose to dextrin is 1:1), uniformly mixing, and preparing into particles (1 g of particles is equivalent to 3g of crude drug).
Comparative example 1
A Chinese herbal medicine immunopotentiator for chicken, which can improve the immunity of chicken and strengthen the disease resistance and disease prevention capability, comprises the following components in parts by weight: 40 parts of echinacea purpurea, 20 parts of astragalus, 10 parts of rhodiola rosea, 20 parts of codonopsis pilosula and 10 parts of liquorice.
The preparation method of the Chinese herbal medicine immunopotentiator for chicken, which can improve the immunity of chicken and strengthen the disease resistance and disease resistance, comprises the following steps:
(1) The raw materials are respectively weighed according to the weight ratio.
(2) Coarse pulverizing the above materials, decocting with 10-12 times of water for 2-3 times each for 1-2 hr, filtering, mixing filtrates, and concentrating the filtrate under reduced pressure to obtain concentrated extract (1 g corresponds to 3g of crude drug).
(3) Adding sucrose and dextrin (sucrose and dextrin are added in a ratio of 1:1) into the concentrated extract obtained in the step 2, uniformly mixing, and preparing into particles (1 g of particles is equivalent to 3g of crude drug).
Comparative example 2
The astragalus pulse-activating drink medicine composition, the preparation method and the feed are calculated according to parts by weight: 50 parts of astragalus, 30 parts of codonopsis pilosula, 25 parts of dwarf lilyturf tuber, 15 parts of schisandra chinensis, 30 parts of echinacea, 25 parts of maca, 20 parts of vitamin C and 20 parts of citric acid.
The medicine composition, the preparation method and the feed preparation method of the astragalus pulse-activating decoction comprise the following steps:
(1) Weighing the traditional Chinese medicine raw materials containing the traditional Chinese medicine components, coarsely crushing, adding 10 parts of water, decocting for 2 times, each time for 1h, filtering, combining the filtrates, concentrating the filtrate under reduced pressure, drying into dry paste, and crushing for standby.
(2) And (3) weighing vitamin C and citric acid respectively, and uniformly mixing with the dry paste powder obtained in the step (1) to obtain the traditional Chinese medicine (1 g of particles is equivalent to 3g of crude medicinal materials).
Comparative example 3
The astragalus pulse-activating decoction comprises the following components in parts by weight: 15 parts of astragalus, 9 parts of codonopsis pilosula, 9 parts of dwarf lilyturf tuber and 5 parts of Chinese magnoliavine fruit.
The preparation method of the astragalus pulse-activating decoction comprises the steps of weighing the medicines of the components, crushing, adding 10 times of water, decocting for 2 times, each time for 1h, filtering, combining filtrate, concentrating the filtrate under reduced pressure to obtain a concentrated extract, adding dextrin, and preparing into granules (1 g of granules is equivalent to 3g of crude drug).
Comparative example 4
50 parts of astragalus, 30 parts of codonopsis pilosula, 28 parts of dwarf lilyturf tuber, 16 parts of schisandra chinensis, 15 parts of cowpea, 20 parts of Chinese fevervine herb and 18 parts of sweet wormwood herb.
The preparation method of the comparative example 4 comprises the following steps:
(1) Weighing the above Chinese medicines, coarse pulverizing, decocting with 10-12 times of water for 2-3 times each for 1-2 hr, filtering, mixing filtrates, and concentrating the filtrate under reduced pressure to obtain concentrated extract (1 g corresponds to 3g of crude drug).
(2) Adding sucrose and dextrin (sucrose and dextrin are added in a ratio of 1:1) into the concentrated extract obtained in the step 1, uniformly mixing, and preparing into particles (1 g of particles is equivalent to 3g of crude drug).
In order to show the effect of the traditional Chinese medicine composition, the applicant further carries out clinical curative effect observation tests on the traditional Chinese medicine composition, and the beneficial effects of the traditional Chinese medicine composition are further illustrated by test examples.
Test example 1 test of the influence of the Chinese medicinal composition of the invention on the antibody level of Newcastle disease vaccine
The immune enhancement effect of the traditional Chinese medicine composition prepared by the embodiment of the invention is examined by observing the influence of the traditional Chinese medicine composition on the antibody level of the newcastle disease vaccine.
1 Material
Test drug: the traditional Chinese medicine compositions prepared in the embodiments 1, 2, 3, 4 and 5 of the invention; the medicaments prepared in comparative examples 1, 2, 3 and 4; control drug: astragalus polysaccharide extract.
The test article is NDV standard antigen and positive serum, and is used for determining the titer of NDVHI antibody.
Test animals: sea blue brown chick
Test method and grouping: 240 sea-blue brown chickens are randomly divided into 12 groups, each group is provided with 4 repeats, 5 chickens are fed on the net for flat raising according to a conventional raising method, and full-price compound feed without any medicine is fed for free feeding and drinking water. Chicks are bred to 14 days old and are immunized for the first time by using an ND vaccine through eye and nose dropping; secondary immunization was performed at 28 days of age with water. The free drinking water administration was continued for 7 days after the first and second days, respectively, and the administration doses were as shown in Table 1 below, 2 chickens were randomly taken from each of the repeated groups at 21 days old and 35 days old, and 8 chickens were collected from each group, 0.2ml was collected intravenously, and the serum was centrifuged at 1.5ml, and the ND antibody level of the chickens was detected by HI method, and the specific grouping and treatment methods were as shown in Table 2 below.
Table 1 test group and dosing conditions
2. Test results and analysis
Table 2 test results
As can be seen from table 2, the antibody level of the group of example 5 was best elevated compared to the control drug, which is the optimal prescription of the present invention. The example 5 group showed a significant increase in both the level of the average antibody at 21 st balance after the first and the level of the average antibody at 35 th balance after the second, compared with the comparative examples 1, 2 and 3, indicating that the formulation of the present invention gave a significant effect compared with the same product as the conventional base formulation. Example 5 the level of the balance 21 was raised from 4.25 to 5.56 and the level of the balance 35 was raised from 6.73 to 7.67 compared to comparative example 4 after the priming, and it was seen that the addition of mannooligosaccharides had a significant synergistic effect.
Test example 2 observation of the prevention Effect of the Chinese medicinal composition of the present invention on New castle disease
And 7 months in 2020, selecting a certain chicken farm in Shandong with a new castle disease history for testing. The 6000 day-old Ev chickens were randomly divided into 4 groups of 1500 chickens, each group being trial 1, trial 2, trial 3 and trial 4. The test 1 group and the test 2 group are the drug groups of the invention, the test 3 group is the test group of the comparative example 1, and the test 1 group is fed freely according to 1 kilogram of the traditional Chinese medicine composition prepared in the embodiment 5 of the invention added into each ton of feed and is continuously administered for 14 days; the test 2 groups are fed with 1 kg of the traditional Chinese medicine composition prepared in the embodiment 1 according to each ton of feed, and are fed for 14 days continuously; the test 3 group uses the medicine of the comparative example 1, and 1 kg of the medicine of the comparative example 1 is added into each ton of feed, and the feed is taken freely and continuously administered for 14 days; test 4 was a blank control group, given no drug, and the feeding conditions were substantially identical. During the test, the isolation protection and disinfection work is done. After the end of administration, the administration was observed for 40 days, and the test results are shown in Table 3.
TABLE 3 Newcastle disease prevention test results
The test results show that the traditional Chinese medicine composition prepared in the embodiment 5 and the embodiment 1 and the medicine in the comparative example 1 can effectively prevent the occurrence of the newcastle disease, the traditional Chinese medicine composition prepared in the embodiment 5 has the best effect, the morbidity is 0, the effective rate can reach 100 percent, the traditional Chinese medicine composition is the optimal prescription of the invention, the effect of preventing the newcastle disease of the medicine composition is far better than that of the medicine group in the comparative example 1, and the difference is obvious compared with the blank control group. The medicine has obvious effect of preventing chicken newcastle disease.
Test example 3 observation of the effect of the Chinese medicinal composition of the present invention on preventing avian influenza
An avian influenza prevention test was performed on a chicken farm of Jiangsu Nanjing with a history of avian influenza, and 2000 chickens were randomly divided into 4 groups of 500 chickens each. Group 1, wherein 1 kg of the traditional Chinese medicine composition prepared in the embodiment 5 of the invention is added into each ton of feed for mixed feeding and administration, and free feeding is carried out for 7 days; group 2, wherein 1 kg of the traditional Chinese medicine composition prepared in the embodiment 3 of the invention is added into each ton of feed, mixed feeding and administration are carried out, and free feeding is carried out for 7 days; group 3, wherein 1 kg of the traditional Chinese medicine composition prepared in the comparative example 4 is added into each ton of feed for mixed feeding and administration, and the feed is freely fed for 7 days; in the first group, no medicine is added into the feed. After the end of administration, the administration was observed for 40 days. The test results are shown in Table 4.
TABLE 4 test results of avian influenza prevention
| Group of | Animal number (head) | Number of animals (head) | Incidence of disease |
| Group 1 (example 5) | 500 | 0 | 0.00％ |
| Group 2 (example 3) | 500 | 1 | 0.200％ |
| Group 3 (comparative example 4) | 500 | 25 | 5.00％ |
| Group 4 (blank) | 500 | 89 | 17.80％ |
The test results show that the traditional Chinese medicine composition of the invention in the embodiment 5 and the embodiment 3 and the medicine of the comparative example 4 have remarkable effects on preventing the avian influenza, and the protection rate of the traditional Chinese medicine composition of the invention can reach 100% and 99.80%, which is better than that of the comparative example 4, so that the traditional Chinese medicine composition has a synergistic effect between the mannooligosaccharide and the traditional Chinese medicine composition of the invention. The differences between the test 1, 2 and 3 groups and the blank control group are significant. The traditional Chinese medicine composition has a very good effect of preventing the avian influenza.
The foregoing is merely a preferred embodiment of the present invention, and it should be noted that it will be apparent to those skilled in the art that several modifications and variations can be made without departing from the technical principle of the present invention, and these modifications and variations should also be regarded as the scope of the invention.
Claims (6)
1. A Chinese medicinal composition for enhancing immunity and disease resistance of poultry is characterized by being prepared from 20-70 parts of astragalus mongholicus, 10-50 parts of codonopsis pilosula, 10-40 parts of radix ophiopogonis, 5-25 parts of schisandra chinensis, 5-20 parts of cowpea, 10-30 parts of Chinese fevervine, 8-26 parts of sweet wormwood and 70-100 parts of mannooligosaccharide.
2. The Chinese medicinal composition for poultry according to claim 1, which is prepared from 30-60 parts of astragalus mongholicus, 20-40 parts of codonopsis pilosula, 20-35 parts of radix ophiopogonis, 10-20 parts of schisandra chinensis, 8-16 parts of cowpea, 15-25 parts of herba paederiae, 12-22 parts of sweet wormwood and 80-90 parts of mannooligosaccharide.
3. The traditional Chinese medicine composition for poultry according to claim 2, which is prepared from 50 parts of astragalus mongholicus, 30 parts of codonopsis pilosula, 28 parts of radix ophiopogonis, 16 parts of schisandra chinensis, 15 parts of cowpea, 20 parts of herba paederiae, 18 parts of sweet wormwood and 85 parts of mannooligosaccharide.
4. A method for preparing the traditional Chinese medicine composition for poultry according to any one of claims 1 to 3, comprising the following steps:
(1) Respectively weighing the raw materials according to the weight proportion;
(2) Pulverizing the other Chinese medicinal materials except for mannooligosaccharide, decocting with 10-12 times of water for 2-3 times each for 1-2 hr, filtering, mixing filtrates, concentrating the filtrate under reduced pressure to obtain concentrated extract, wherein 1g is equivalent to 3g of crude drug;
(3) Adding weighed mannooligosaccharide into the concentrated extract obtained in the step (2), uniformly mixing, adding sucrose and dextrin, uniformly mixing, and preparing into particles.
5. The method of claim 4, wherein in the step (3), the adding ratio of sucrose to dextrin is 1:1.
6. use of the Chinese medicinal composition for poultry according to any one of claims 1 to 3 for preparing a medicament for enhancing immunity and disease resistance of poultry organisms.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110890039.5A CN113577189B (en) | 2021-08-04 | 2021-08-04 | Traditional Chinese medicine composition for poultry and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110890039.5A CN113577189B (en) | 2021-08-04 | 2021-08-04 | Traditional Chinese medicine composition for poultry and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113577189A CN113577189A (en) | 2021-11-02 |
| CN113577189B true CN113577189B (en) | 2024-04-16 |
Family
ID=78254838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110890039.5A Active CN113577189B (en) | 2021-08-04 | 2021-08-04 | Traditional Chinese medicine composition for poultry and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113577189B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1079397A (en) * | 1993-01-01 | 1993-12-15 | 山东北方制药厂 | Improve Chinese medicine of body function and preparation method thereof |
-
2021
- 2021-08-04 CN CN202110890039.5A patent/CN113577189B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1079397A (en) * | 1993-01-01 | 1993-12-15 | 山东北方制药厂 | Improve Chinese medicine of body function and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 汉中苗族聚居区20种药用植物资源调查报告;王仕宝等;承德医学院学报;第31卷(第6期);496页右栏第3段和498页左栏第6段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113577189A (en) | 2021-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103169773B (en) | Traditional Chinese medicine compound preparation for enhancing livestock immunity and preparation method | |
| CN105168807B (en) | The Chinese medicine composition and preparation method thereof for treating pig blue-ear disease | |
| CN103860616B (en) | Siberian Ginseng P.E and its preparation and application | |
| CN102688323A (en) | Chinese veterinary drug granule for improving immunologic function of livestock and preparation method thereof | |
| CN102274303A (en) | Traditional Chinese medicine extract compound injection for treating yellow-white dysentery of piglets and preparation method | |
| CN113577189B (en) | Traditional Chinese medicine composition for poultry and preparation method and application thereof | |
| CN106039138A (en) | Lactic acid bacteria traditional Chinese medicine fermentation antiviral preparation for aquaculture | |
| CN102949408B (en) | Pharmaceutical composition capable of strengthening immunity of poultry and method for preparing pharmaceutical composition | |
| CN106924352B (en) | Application of traditional Chinese medicine composition | |
| CN102078600B (en) | Anti-cancer compound ganoderma composition, application thereof and pharmaceutical composition containing same | |
| CN104524555A (en) | Traditional Chinese medicinal oral liquid for enhancing livestock and poultry immunity and preparation method of oral liquid | |
| CN104784327B (en) | A kind of Chinese veterinary medicinal composition for treating chicken respiratory tract disease and preparation method thereof | |
| CN1686424A (en) | Medicinal composition containing scutellaria and bupleurum and its preparation method | |
| CN103417653B (en) | Veterinary-use compound pure Chinese herbal medicine for treating coccidium and preparation method of oral liquid of same | |
| CN101314033A (en) | Oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof | |
| CN111544570B (en) | Antiviral preparation added with antibacterial peptide and preparation method thereof | |
| CN113940966B (en) | Callicarpa nudiflora composition for treating escherichia coli infection and preparation method and application thereof | |
| CN105770054A (en) | Pharmaceutical composition for preventing and treating chicken coccocidiosis, additive and feed | |
| CN109498701A (en) | A kind of Chinese medicine composition and its preparation method and application for preventing and treating goose paramyxovirus | |
| Mohamed et al. | The effect of some immunomodulators like Propolis and Immulant® against live Newcastle disease virus vaccination on broiler chickens, Egypt | |
| CN105982952B (en) | A pharmaceutical composition, ZIGUANBAOGEN, comprises premix, concentrate and batch | |
| CN115607594A (en) | Traditional Chinese medicine composition for preventing and treating necrotic enteritis of poultry and application thereof | |
| CN107094996B (en) | Pomegranate peel-containing composite plant extract and preparation method and application thereof | |
| CN106880686B (en) | Traditional Chinese medicine premix for preventing and treating piglet diarrhea and preparation method thereof | |
| CN104491140B (en) | Medicinal liquid preparation for treating animal viral fever diseases and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20220718 Address after: 101407 Beijing city Huairou District Yanqi Economic Development Zone No. 10 North Street Applicant after: Beijing Dabeinong Animal Health Care Technology Co.,Ltd. Applicant after: Shaoshan Da Bei Nong Animal Pharmaceutical Co., Ltd. Address before: 101407 Beijing city Huairou District Yanqi Economic Development Zone No. 10 North Street Applicant before: Beijing Dabeinong Animal Health Care Technology Co.,Ltd. Applicant before: Shaoshan Dabeinong Animal Medicine Co.,Ltd. Applicant before: BEIJING DABEINONG TECHNOLOGY GROUP Co.,Ltd. |
|
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |